Elevation Oncology (ELEV) Short Interest Ratio & Short Volume → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free ELEV Stock Alerts $3.62 -0.02 (-0.55%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Elevation Oncology Short Interest DataCurrent Short Volume4,950,000 sharesPrevious Short Volume5,010,000 sharesChange Vs. Previous Month-1.20%Dollar Volume Sold Short$21.93 millionShort Interest Ratio / Days to Cover4.2Last Record DateApril 15, 2024Outstanding Shares48,650,000 sharesFloat Size37,990,000 sharesShort Percent of Float13.03%Today's Trading Volume872,578 sharesAverage Trading Volume828,929 sharesToday's Volume Vs. Average105% Short Selling Elevation Oncology ? Sign up to receive the latest short interest report for Elevation Oncology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatELEV Short Interest Over TimeELEV Days to Cover Over TimeELEV Percentage of Float Shorted Over Time Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 Elevation Oncology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20244,950,000 shares $21.93 million -1.2%13.0%4.2 $4.43 3/31/20245,010,000 shares $25.70 million +8.2%12.6%1.6 $5.13 3/15/20244,630,000 shares $20.33 million +28.3%11.6%1.6 $4.39 2/29/20243,610,000 shares $15.92 million -10.0%9.1%1.3 $4.41 2/15/20244,010,000 shares $11.11 million +13.9%11.6%1.5 $2.77 1/31/20243,520,000 shares $9.79 million +95.6%10.1%1.4 $2.78 Get the Latest News and Ratings for ELEV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Elevation Oncology and its competitors with MarketBeat's FREE daily newsletter. 1/15/20241,800,000 shares $4.93 million +124.0%5.2%0.8 $2.74 12/31/2023803,700 shares $431,586.90 +21.0%2.5%0.5 $0.54 12/15/2023664,500 shares $338,961.45 +12.0%2.1%2.8 $0.51 11/30/2023593,500 shares $315,742.00 -10.8%1.8%2.7 $0.53 11/15/2023665,100 shares $307,276.20 -22.3%2.1%2.9 $0.46 10/31/2023856,100 shares $410,928.00 -8.2%2.8%4.1 $0.48 10/15/2023932,200 shares $616,184.20 +0.6%3.1%5.6 $0.66 9/30/2023926,500 shares $613,898.90 -24.7%3.1%4.9 $0.66 9/15/20231,230,000 shares $895,440.00 +1.7%4.1%5.5 $0.73 8/31/20231,210,000 shares $924,440.00 -4.7%5.2%2.6 $0.76 8/15/20231,270,000 shares $1.16 million +0.8%5.4%0.8 $0.91 7/31/20231,260,000 shares $1.51 million -4.6%4.7%0.7 $1.20 7/15/20231,320,000 shares $1.97 million -11.4%8.6%0.7 $1.49 6/30/20231,490,000 shares $2.26 million -4.5%9.8%0.8 $1.52 6/15/20231,560,000 shares $2.31 million -39.3%10.2%0.8 $1.48 5/31/20232,570,000 shares $10.85 million +596.3%16.4%1.2 $4.22 5/15/2023369,100 shares $1.35 million -64.2%2.3%0.4 $3.67 4/30/20231,030,000 shares $2.71 million +688.7%6.7%1.3 $2.63 4/15/2023130,600 shares $254,670.00 +6.0%0.9%0.3 $1.95 3/31/2023123,200 shares $234,080.00 +135.6%0.8%0.2 $1.90 3/15/202352,300 shares $121,336.00 +28.2%0.3%0.1 $2.32 2/28/202340,800 shares $44,982.00 +22.5%0.3%0.4 $1.10 2/15/202333,300 shares $32,634.00 -18.2%0.2%0.4 $0.98 1/31/202340,700 shares $40,700.00 +20.8%0.3%0.5 $1.00 1/15/202333,700 shares $33,396.70 -29.4%0.2%0.4 $0.99 12/30/202247,700 shares $45,315.00 +10.7%0.3%0.7 $0.95 12/15/202243,100 shares $40,945.00 -2.1%0.3%1.1 $0.95 11/30/202244,000 shares $39,776.00 -10.4%0.3%1 $0.90 11/15/202249,100 shares $47,627.00 +6.1%0.3%1 $0.97 10/31/202246,300 shares $50,004.00 +42.5%0.3%0.9 $1.08 10/15/202232,500 shares $35,425.00 -62.7%0.2%0.5 $1.09 9/30/202287,200 shares $98,536.00 +76.5%0.6%1.1 $1.13 9/15/202249,400 shares $61,750.00 -12.6%0.3%0.5 $1.25 8/31/202256,500 shares $64,975.00 +61.4%0.4%0.4 $1.15Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. ELEV Short Interest - Frequently Asked Questions What is Elevation Oncology's current short interest? Short interest is the volume of Elevation Oncology shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 4,950,000 shares of ELEV short. 13.03% of Elevation Oncology's shares are currently sold short. Learn More on Elevation Oncology's current short interest. What is a good short interest ratio for Elevation Oncology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ELEV shares currently have a short interest ratio of 4.0. Learn More on Elevation Oncology's short interest ratio. What is a good short interest percentage for Elevation Oncology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.03% of Elevation Oncology's floating shares are currently sold short. Is Elevation Oncology's short interest increasing or decreasing? Elevation Oncology saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 4,950,000 shares, a drop of 1.2% from the previous total of 5,010,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Elevation Oncology's float size? Elevation Oncology currently has issued a total of 48,650,000 shares. Some of Elevation Oncology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Elevation Oncology currently has a public float of 37,990,000 shares. How does Elevation Oncology's short interest compare to its competitors? 13.03% of Elevation Oncology's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Elevation Oncology: Compass Therapeutics, Inc. (1.88%), Poseida Therapeutics, Inc. (6.55%), X4 Pharmaceuticals, Inc. (7.30%), Century Therapeutics, Inc. (6.91%), Opthea Limited (0.21%), Adverum Biotechnologies, Inc. (7.54%), Innate Pharma S.A. (0.10%), Acumen Pharmaceuticals, Inc. (2.40%), Sutro Biopharma, Inc. (3.49%), Cardiff Oncology, Inc. (8.93%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Elevation Oncology stock? Short selling ELEV is an investing strategy that aims to generate trading profit from Elevation Oncology as its price is falling. ELEV shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Elevation Oncology? A short squeeze for Elevation Oncology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ELEV, which in turn drives the price of the stock up even further. How often is Elevation Oncology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ELEV, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: CMPX Short Interest Data PSTX Short Interest Data XFOR Short Interest Data IPSC Short Interest Data OPT Short Interest Data ADVM Short Interest Data IPHA Short Interest Data ABOS Short Interest Data STRO Short Interest Data CRDF Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ELEV) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressWhy Big Pharma is Investing Billions in This BiotechBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlaceThe only accurate crypto trading system I know …Weiss Ratings